Lipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response

Journal of Immunology

Volumn 163, Issue 5, 1999, Pages 2792-2798

  Vreugdenhil, Anita C E ^a   Dentener, Mieke A ^a   Snoek, A M P ^a   Greve, Jan Willem M ^a   Buurman, Wim A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; GLUCOCORTICOID; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE BINDING PROTEIN; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ARTICLE; BACTERIAL INFECTION; CELL STRAIN CACO 2; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INFLAMMATION; INTESTINE EPITHELIUM CELL; LIVER CELL; MEDIATOR RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; TIME;

ACUTE-PHASE PROTEINS; ACUTE-PHASE REACTION; ADJUVANTS, IMMUNOLOGIC; APOLIPOPROTEINS; CACO-2 CELLS; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELL LINE; CYTOKINES; DEXAMETHASONE; ENDOTOXINS; ESCHERICHIA COLI; HUMANS; ILEUM; INTESTINAL MUCOSA; JEJUNUM; KINETICS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; SERUM AMYLOID A PROTEIN; TIME FACTORS;

EID: 0033198064     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Schumann, R. R., S. R. Leong, G. W. Flaggs, P. W. Gray, S. W. Wright, J. C. Mathison, and R. J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science 249:1429.
2. Wurfel, M. M., E. Hailman, and S. D Wright. 1995. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J. Exp. Med. 181:1743.
3. Ulevitch, R. J., A. R. Johnston, and D. B. Weinstein. 1979. New function for high density lipoproteins. J. Clin. Invest. 64:1516.
4. Lamping, N., R. Dettmer, N. W. J. Schröder, D. Pfeil, W. Hallatschek, R. Burger, and R. R. Schumann. 1998. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria. J. Clin. Invest. 101:2065.
5. Michalsky, M. P., E. A. Deitch, J. Ding, Q. Lu, and Q. Huang. 1997. Interleukin-6 and tumor necrosis factor production in an enterocyte cell model (Caco-2) during exposure to Escherichia coli. Shock 7:139.
6. Porter, E. M., L. Liu, A. Oren, P. A. Anton, and T. Ganz. 1997. Localization of human intestinal defensin 5 in Paneth cell granules. Infect. Immun. 65:2389.
7. Su, G. L., P. D. Freeswick, D. A. Geller, Q. Wang, R. A. Shapiro, Y. H. Wan, T. R. Billiar, D. J Tweardy, R. L. Simmons, and S. C. Wang. 1994. Molecular cloning, characterization, and tissue distribution of rat lipopolysaccharide binding protein. J. Immunol. 153:743.
8. Molmenti, E. P., T. Ziambaras, and D. H. Perlmutter. 1993. Evidence for an acute phase response in human intestinal epithelial cells. J. Biol. Chem. 268:14116.
9. Kisilevsky, R., and L. Subrahmanyan. 1992. Serum amyloid A changes high density lipoprotein's cellular affinity. Lab. Invest. 66:778.
10. Hidalgo, I. J., T. J. Raub, and R. T. Borchardt. 1989. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96:736.
11. Hansen, M. B., S. E. Nielsen, and K. Berg. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 19:203.
12. Kloppenburg, M., B. M. N. Brinkman, H. H. Rooij-Dijk, A. M. M. Miltenburg, M. R. Daha, F. C. Breedveld, B. A. C. Dijkmans, and C. L. Verweij. 1996. The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes. Antimicrob. Agents Chemother. 40:934.
13. Froon, A. H. M,. M. A. Dentener, J. W. M. Greve, G. Ramsay, and W. A. Buurman. 1995. Lipopolysaccharide toxicity-regulating proteins in bacteremia. J. Infect. Dis. 171:1250.
14. the International Symposium on Amyloidosis, August 5-8. J. B. Natvig, ed. Kluwer, Dordrecht, The Netherlands, p. 898.
15. Steel, D. M., F. C. Donoghue, R. M. O'Neill, C. M. Uhlar, and A. S. Whitehead. 1996. Expression and regulation of constitutive and acute phase serum amyloid A mRNAs in hepatic and non-hepatic cell lines. Scand. J. Immunol. 44:493.
16. Tateishi, H., K. Mitsuyama, A. Toyonaga, M. Tomoyose, and K. Tanikawa. 1997. Role of cytokines in experimental colitis: relation to intestinal permeability. Digestion 58:271.
17. Bertrand, V., R. Guimbaud, M. Tulliez, C. Mauprivez, P. Sogni, D. Couturier, J.-P. Giroud, S. Chaussade, and L. Chauvelot-Moachon. 1998. Increase in tumor necrosis factor-a production linked to the toxicity of indomethacin for the rat small intestine. Br. J. Phamacol. 124:1385.
18. Tamion, F., V. Richard, S. Lyoumi, M. Daveau, G. Bonmarchand, J. Leroy, C. Thuillez, and J.-P. Lebreton. 1997. Gut ischaemia and mesenteric synthesis of inflammatory cytokines after hemorrhagic or endotoxic shock. Am. J. Physiol. 273:G314.
19. Schumann, R. R., C. J. Kirschning, A. Unbehaun, H. Aberle, H. P. Knopf, N. Lamping, R. J. Ulevitch, and F. Herrmann. 1996. The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT-3 and other cytokine-inducible nuclear proteins. Mol. Cell. Biol. 7:3490.
20. McAdam, K. P. W. J, and J. D. Sipe. 1976. Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein. J. Exp. Med. 144:1121.
21. Grube, B. J., C. G. Cochane, R. D. Ye, C. E. Green, M. E. McPhail, R. J. Ulevitch, and P. S. Tobias. 1994. Lipopolysaccharide binding protein expression in primary human hepatocytes and HepG2 hepatoma cells. J. Biol. Chem.269:8477.
22. Wan, Y., P. D. Freeswick, L. S. Khemlani, P. H. Kispert, S. C. Eang, G. L. Su, and T. R. Billiar. 1995. Role of lipopolysaccharide (LPS), interleukin-1, interleukin-6, tumor necrosis factor, and dexamethasone in regulation of LPS-binding protein expression in normal hepatocytes and hepatocytes from LPS treated rats. Infect. Immun. 63:2435.
23. Raynes, J. G., S. Eagling, and K. P. W. J. McAdam. 1991. Acute-phase protein synthesis in human hepatoma cells: differential regulation of serum amyloid A (SAA) and haptoglobin by interleukin-1 and interleukin-6. Clin. Exp. Immunol. 83:448.
24. Smith, J. W., and T. L. McDonald. 1992. Production of serum amyloid A and C-reactive protein by HepG2 cells stimulated with combinations of cytokines or monocyte conditioned media: the effects of prednisolone. Clin. Exp. Immunol. 90:293.
25. Viscardi, R. M., N. H. Lyon, C. C. Sun, J. R. Hebel, and I. D. Hasday. 1997. Inflammatory cytokine mRNAs in surgical specimens of necrotizing enterocolitis and normal newborn intestine. Pediatr. Pathol. Lab. Med. 17:547.
26. Youngman, K. R., P. L. Simon, G. A. West, F. Cominelli, D. Rachmilewitz, J. S. Klein, and C. Fiocchi. 1993. Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells. Gastroenterology 104: 749.
27. Ogle, C. K., X, Guo, P. O. Hasselgren, J. D. Ogle, and J. W. Alexander. 1997. The gut as a source of inflammatory cytokines after stimulation with endotoxin. Eur. J. Surg. 163:45.
28. Massamiri, T., P. S. Tobias, and L. K. Curtiss, 1997. Structural determinants for the interaction of lipopolysaccharide binding protein with purified high density lipoproteins: role of apolipoprotein A-I. J. Lipid Res. 38:516.
29. Wurfel, M. M., and S. D. Wright, 1997. Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers. J. Immunol. 158:3925.
30. Jack, R. S., X. Fan, M. Bernheiden, G. Rune, M. Ehlers, A. Weber, G. Kirsch, R. Mentel, B. Fürll, M. Freudenberg, et al. 1997. Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection. Nature 389:742.
31. Patel, H., R. Fellowes, S. Coade, and P. Woo. 1998. Human serum amyloid A has cytokine-like properties. Scand. J. Immunol. 48:410.